Pages that link to "Q34382971"

The following pages link to Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? (Q34382971):

Displaying 44 items.

• Adult stem or progenitor cells in treatment for type 1 diabetes: current progress (Q24655207) (← links)
• Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update (Q26798145) (← links)
• Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells (Q28247710) (← links)
• Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model (Q28472232) (← links)
• A new strategy to generate functional insulin-producing cell lines by somatic gene transfer into pancreatic progenitors (Q28474941) (← links)
• Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes (Q30416868) (← links)
• Proendocrine genes coordinate the pancreatic islet differentiation program in vitro (Q30448603) (← links)
• Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice (Q30875559) (← links)
• Current status of islet cell replacement and regeneration therapy (Q33738705) (← links)
• Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucose-responsive synthetic promoter (Q33759358) (← links)
• Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells (Q34085147) (← links)
• Minireview: beta-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation (Q34132171) (← links)
• Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy (Q34485165) (← links)
• Gene therapy in diabetes (Q34619696) (← links)
• Cell replacement therapy for type 1 diabetes (Q34735277) (← links)
• Chronic diabetic complications: the body's adaptive response to hyperglycemia gone awry? (Q34767192) (← links)
• Vectors for the treatment of autoimmune disease. (Q35122178) (← links)
• Hepatic Insulin Gene Therapy in Insulin-Dependent Diabetes Mellitus (Q35544053) (← links)
• In vivo gene therapy for diabetes mellitus (Q35558681) (← links)
• Stem cells: a promising source of pancreatic islets for transplantation in type 1 diabetes (Q35622965) (← links)
• Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications (Q35651511) (← links)
• Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine (Q35934188) (← links)
• GPR41 gene expression is mediated by internal ribosome entry site (IRES)-dependent translation of bicistronic mRNA encoding GPR40 and GPR41 proteins. (Q36016849) (← links)
• New sources of pancreatic beta-cells (Q36186494) (← links)
• Generation, culture, and differentiation of human embryonic stem cells for therapeutic applications (Q36293910) (← links)
• Current cell-based approaches for the treatment of diabetes mellitus (Q37024716) (← links)
• 'Not taken in by media hype': how potential donors, recipients and members of the general public perceive stem cell research (Q37155521) (← links)
• Stem cell therapy for type 1 diabetes mellitus (Q37696268) (← links)
• Reprogramming gut and pancreas endocrine cells to treat diabetes. (Q37913508) (← links)
• Restoring insulin production for type 1 diabetes. (Q37994917) (← links)
• Insulin gene therapy from design to beta cell generation. (Q38051768) (← links)
• Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration (Q41848708) (← links)
• Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer (Q44042218) (← links)
• NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice (Q44409461) (← links)
• Selection of insulin-producing rat insulinoma (RINm) cells with improved resistance to oxidative stress (Q44461914) (← links)
• Glucose-Responsive Hepatic Insulin Gene Therapy of Spontaneously Diabetic BB/Wor Rats (Q44631501) (← links)
• Plasmid-electroporated primary hepatocytes acquire quasi-physiological secretion of human insulin and restore euglycemia in diabetic mice (Q45259633) (← links)
• Hepatic insulin gene therapy normalizes diurnal fluctuation of oxidative metabolism in diabetic BB/Wor rats (Q45877782) (← links)
• Derivation of islet-like cells from mesenchymal stem cells using PDX1-transducing lentiviruses (Q45886703) (← links)
• Treatment of diabetes by transplantation of drug-inducible insulin-producing gut cells. (Q46040004) (← links)
• Mapping the structural topology of IRS family cascades through computational biology (Q49941132) (← links)
• Efficient restricted gene expression in beta cells by lentivirus-mediated gene transfer into pancreatic stem/progenitor cells. (Q50775515) (← links)
• Beta-cell precursors--a work in progress (Q51624927) (← links)
• Regenerative medicine and cell-based approaches to restore pancreatic function. (Q52543005) (← links)